INFLUENCE OF BETARGIN AND QUERCETIN ON INDICATORS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE


  • Yu. Kazakov Ukrainian Medical Stomatological Academy, Ukraine
  • Yu. Manusha Ukrainian Medical Stomatological Academy, Ukraine
  • V. Hliebov Ukrainian Medical Stomatological Academy, Ukraine
  • V. Boriak Ukrainian Medical Stomatological Academy, Ukraine
  • V. Sakevych Ukrainian Medical Stomatological Academy, Ukraine
Keywords: coronary heart disease, non-alcoholic fatty liver disease, chronic systemic inflammation, quercetin, betargin.

Abstract

INFLUENCE OF BETARGIN AND QUERCETIN ON INDICATORS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE

References

1. Van Weel, C. & Schellevis, F.G., 2006. Comorbidity and guidelines: conflicting interests. Lancet. 367, pp. 550-551.

2. Corey, K.E. & Vuppalanchi, R., 2012. Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease. Clinical Liver Disease. 1(4), pp. 114-116.

3. Lubrano, V. & Balzan, S., 2015. Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med. 5(1), pp. 21-32.

4. Bril, F, Sninsky, J.J., Baca, A.M., Superko, H.R., Portillo, S.P., Biernacki D., et al., 2016. Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD. J Clin Endocrinol Metab. 101(2), p. 644-652.

5. Lee, I., 2015. Betaine is a positive regulator of mitochondrial respiration. Biochemical and Biophysical Research Communications. 456, pp. 621-625.

6. Egorov, A.M., Osipov, A.P., Dzantiev, B.B., &Gavrilova, E.M., 1991. Teorijaipraktikaimmunofermentnogoanaliza. Moskow: Vysshajashkola, 288p.

7. Livak,K.J.&Schmittgen, T.D.,2001. Analysisofrelativegeneexpressiondatausingreal-timequantitativePCRandthe 2(-DeltaDeltaC(T)) Method.Methods. 25, pp. 402-408.
Published
2019-11-07
How to Cite
Kazakov, Y., Manusha, Y., Hliebov, V., Boriak, V., & Sakevych, V. (2019). INFLUENCE OF BETARGIN AND QUERCETIN ON INDICATORS OF CHRONIC SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE CONCURRENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 52-53. https://doi.org/10.29256/v.03.01.2019.escbm33
Section
Selected abstracts